These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12669360)

  • 1. [GMOs and production of pharmaceutical molecules].
    Faye L; Lerouge P; Gomord V
    Bull Acad Natl Med; 2002; 186(8):1411-25. PubMed ID: 12669360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Plant-made pharmaceuticals].
    Faye L; Lerouge P; Gomord V
    Ann Pharm Fr; 2003 Mar; 61(2):109-18. PubMed ID: 12668949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production and glycosylation of plant-made pharmaceuticals: the antibodies as a challenge.
    Gomord V; Sourrouille C; Fitchette AC; Bardor M; Pagny S; Lerouge P; Faye L
    Plant Biotechnol J; 2004 Mar; 2(2):83-100. PubMed ID: 17147602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody processing and engineering in plants, and new strategies for vaccine production.
    Ma JK; Drake PM; Chargelegue D; Obregon P; Prada A
    Vaccine; 2005 Mar; 23(15):1814-8. PubMed ID: 15734047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plant biopharming of monoclonal antibodies.
    Ko K; Koprowski H
    Virus Res; 2005 Jul; 111(1):93-100. PubMed ID: 15896408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of antibodies in plants: status after twenty years.
    De Muynck B; Navarre C; Boutry M
    Plant Biotechnol J; 2010 Jun; 8(5):529-63. PubMed ID: 20132515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges in therapeutic glycoprotein production.
    Sethuraman N; Stadheim TA
    Curr Opin Biotechnol; 2006 Aug; 17(4):341-6. PubMed ID: 16828275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Alternative production systems for therapeutic monoclonal antibodies].
    Olivier S; Mehtali M
    Med Sci (Paris); 2009 Dec; 25(12):1163-8. PubMed ID: 20035699
    [No Abstract]   [Full Text] [Related]  

  • 9. Expression and characterization of an anti-(hepatitis B surface antigen) glycosylated mouse antibody in transgenic tobacco (Nicotiana tabacum) plants and its use in the immunopurification of its target antigen.
    Ramírez N; Rodríguez M; Ayala M; Cremata J; Pérez M; Martínez A; Linares M; Hevia Y; Páez R; Valdés R; Gavilondo JV; Selman-Housein G
    Biotechnol Appl Biochem; 2003 Dec; 38(Pt 3):223-30. PubMed ID: 12797866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opportunities for recombinant antigen and antibody expression in transgenic plants--technology assessment.
    Schillberg S; Twyman RM; Fischer R
    Vaccine; 2005 Mar; 23(15):1764-9. PubMed ID: 15734038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downstream processing of recombinant proteins from transgenic feedstock.
    Nikolov ZL; Woodard SL
    Curr Opin Biotechnol; 2004 Oct; 15(5):479-86. PubMed ID: 15464381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The production of recombinant pharmaceutical proteins in plants.
    Ma JK; Drake PM; Christou P
    Nat Rev Genet; 2003 Oct; 4(10):794-805. PubMed ID: 14526375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production and localization of recombinant pharmaceuticals in transgenic seeds.
    Rademacher T; Arcalis E; Stoger E
    Methods Mol Biol; 2009; 483():69-87. PubMed ID: 19183894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of recombinant proteins in suspension-cultured plant cells.
    Plasson C; Michel R; Lienard D; Saint-Jore-Dupas C; Sourrouille C; de March GG; Gomord V
    Methods Mol Biol; 2009; 483():145-61. PubMed ID: 19183898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An integral approach towards a practical application for a plant-made monoclonal antibody in vaccine purification.
    Pujol M; Ramírez NI; Ayala M; Gavilondo JV; Valdés R; Rodríguez M; Brito J; Padilla S; Gómez L; Reyes B; Peral R; Pérez M; Marcelo JL; Milá L; Sánchez RF; Páez R; Cremata JA; Enríquez G; Mendoza O; Ortega M; Borroto C
    Vaccine; 2005 Mar; 23(15):1833-7. PubMed ID: 15734051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient co-expression for fast and high-yield production of antibodies with human-like N-glycans in plants.
    Vézina LP; Faye L; Lerouge P; D'Aoust MA; Marquet-Blouin E; Burel C; Lavoie PO; Bardor M; Gomord V
    Plant Biotechnol J; 2009 Jun; 7(5):442-55. PubMed ID: 19422604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of plant N-glycans processing: the future of producing therapeutic protein by transgenic plants.
    Chen M; Liu X; Wang Z; Song J; Qi Q; Wang PG
    Med Res Rev; 2005 May; 25(3):343-60. PubMed ID: 15499575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal and recombinant antibodies, 30 years after ..
    Laffly E; Sodoyer R
    Hum Antibodies; 2005; 14(1-2):33-55. PubMed ID: 16424599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plant-made pharmaceuticals: leading products and production platforms.
    Paul M; Ma JK
    Biotechnol Appl Biochem; 2011; 58(1):58-67. PubMed ID: 21446960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of plantibodies in Nicotiana plants.
    Ayala M; Gavilondo J; Rodríguez M; Fuentes A; Enríquez G; Pérez L; Cremata J; Pujol M
    Methods Mol Biol; 2009; 483():103-34. PubMed ID: 19183896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.